High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 8, 2007, Pages 1097-1105

  Sandner, Dirk ^a   Herbrig, Erdmuth ^a   Engelmann, Katrin ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Medical Centre Chemnitz   (Germany)

Author keywords

Heavy silicone oil; Ocular endotamponade; Perfluorohexyloctane; Proliferative vitreoretinopathy; Retinal detachment

Indexed keywords

FIBRIN; SILICONE OIL;

ADULT; AGED; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOCOAGULATION; DEVICE REMOVAL; EYE INFLAMMATION; FEMALE; FOLLOW UP; GRAFT FAILURE; HUMAN; HYPOPYON; INTRAOCULAR HYPERTENSION; LASER COAGULATION; MALE; MYOPIA; OCULAR FIBROSIS; OPERATION DURATION; OPTICAL RESOLUTION; PRIORITY JOURNAL; RECURRENCE RISK; RETINA DETACHMENT; RETINA SURGERY; RETINOTOMY; SCLERA BUCKLING PROCEDURE; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY; VITREOUS HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; CRYOTHERAPY; DRAINAGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER COAGULATION; MALE; MIDDLE AGED; RECURRENCE; RETINAL DETACHMENT; SILICONE OILS; TIME FACTORS; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE;

EID: 34447129332     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0496-y     Document Type: Article

References (43)

1. Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R (1991) Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina 11:367-374
2. Chang S, Zimmerman NJ, Iwamoto T, Ortiz R, Faris D (1987) Experimental vitreous replacement with perfluorotributylamine. Am J Ophthalmol 103:29-37
3. Dresp JH, Menz D-H (2005) Interaction of different ocular endotamponades as a risk factor for silicone oil emulsification. Retina 25:902-910
4. Falkner CI, Binder S, Kruger A (2001) Outcome after silicone oil removal. Br J Ophthalmol 85:1324-1327
5. Fisk MJ, Cairns JD (1995) Silicone oil insertion. A review of 127 consecutive cases. Aust N Z J Ophthalmol 23:25-32
6. Flaxel CJ, Mitchell SM, Aylward GW (2000) Visual outcome after silicone oil removal and recurrent retinal detachment repair. Eye 14:834-838
7. Gabel VP, Kampik A, Gabel C, Spiegel D (1987) Silicone oil with high specific gravity for intraocular use. Br J Ophthalmol 71:262-267
8. Gerding H, Kolck A (2004) [Perfluorohexyloctane as internal tamponade in patients with complicated retinal detachment. Results after 6 months]. Ophthalmologe 101:255-262
9. Gremillion CM Jr, Peyman GA, Liu KR, Naguib KS (1990) Fluorosilicone oil in the treatment of retinal detachment. Br J Ophthalmol 74:643-646
10. Hiscott P, Magee RM, Colthurst M, Lois N, Wong D (2001) Clinicopathological correlation of epiretinal membranes and posterior lens opacification following perfluorohexyloctane tamponade. Br J Ophthalmol 85:179-183
11. Hoerauf H, Kobuch K, Dresp J, Menz DH (2001) Combined use of partially fluorinated alkanes, perfluorocarbon liquids and silicone oil: An experimental study. Graefes Arch Clin Exp Ophthalmol 239:373-381
12. Jonas JB, Knorr HL, Rank RM, Budde WM (2001) Retinal redetachment after removal of intraocular silicone oil tamponade. Br J Ophthalmol 85:1203-1207
13. Kampik A, Hoing C, Heidenkummer HP (1992) Problems and timing in the removal of silicone oil. Retina 12:S11-S16
14. Kirchhof B, Wong D, Van Meurs J, Hilgers RD, Macek M, Lois N, Schrage NF (2002) Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 133:95-101
15. Kobuch K, Menz IH, Hoerauf H, Dresp JH, Gabel VP (2001) New substances for intraocular tamponades: Perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 239:635-642
16. La Heij EC, Hendrikse F, Kessels AG (2001) Results and complications of temporary silicone oil tamponade in patients with complicated retinal detachments. Retina 21:107-114
17. Lucke K, Laqua H (1990) Proliferative vitreoretinopathy silicone oil in the treatment of complicated retinal detachments. Springer, Berlin Heidelberg New York, pp 81-88
18. Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM (1991) An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 112:159-165
19. Malchiodi-Albedi F, Matteucci A, Formisano G, Paradisi S, Carnovale-Scalzo G, Perilli R, Scorcia G, Caiazza S (2003) Perfluorohexyloctane (F6H8) induces structural modifications and increases apoptosis in rat primary retinal cultures. J Biomed Mater Res B Appl Biomater 65:133-136
20. Meinert H, Roy T (2000) Semifluorinated alkanes - a new class of compounds with outstanding properties for use in ophthalmology. Eur J Ophthalmol 10:189-197
21. Mertens S, Bednarz J, Engelmann K (2002) Evidence of toxic side effects of perfluorohexyloctane after vitreoretinal surgery as well as in previously established in vitro models with ocular cell types. Graefes Arch Clin Exp Ophthalmol 240:989-995
22. Miyamoto K, Refojo MF, Tolentino FI, Fournier GA, Albert DM (1984) Perfluoroether liquid as a long-term vitreous substitute. An experimental study. Retina 4:264-268
23. Nabih M, Peyman GA, Clark LC Jr, Hoffman RE, Miceli M, Abou-Steit M, Tawakol M, Liu KR (1989) Experimental evaluation of perfluorophenanthrene as a high specific gravity vitreous substitute: A preliminary report. Ophthalmic Surg 20:286-293
24. Pastor JC, Mendez MC, de la Fuente MA, Coco RM, Garcia-Arumi J, Rodriguez de la Rua E, Fernandez N, Saornil MA, Gayoso MJ (2006) Intraretinal immunohistochemistry findings in proliferative vitreoretinopathy with retinal shortening. Ophthalmic Res 38:193-200
25. Roider J, Hoerauf H, Kobuch K, Gabel VP (2002) Clinical findings on the use of long-term heavy tamponades (semifluorinated alkanes and their oligomers) in complicated retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 240:965-971
26. Sandner D, Engelmann K (2006) First experiences with high-density silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment Graefes Arch Clin Exp Ophthalmol 244:609-619
27. Schatz B, El-Shabrawi Y, Haas A, Langmann G (2004) Adverse side effects with perfluorohexyloctane as a long-term tamponade agent in complicated vitreoretinal surgery. Retina 24:567-573
28. Schatz B, Langmann G, Faulborn J (2001) Erfahrungen mit Fluoron (F6H8) als Tamponade in der komplexen Netzhautchirurgie. Spektrum Augenheilkd 15:238-241
29. Scott IU, Flynn HW, Lai M, et al (2000) First operation anatomic success and other predictors of postoperative vision after complex retinal detachment repair with vitrectomy and silicone oil tamponade. Am J Ophthalmol 130:745-750
30. Sethi CS, Lewis GP, Fisher SK, Leitner WP, Mann DL, Luthert PJ, Charteris DG (2005) Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 46:329-342
31. Sharma T, Gopal L, Shanmugam MP, et al (2002) Management of recurrent retinal detachment in silicone oil-filled eyes. Retina 22:153-157
32. Sparrow JR, Matthews GP, Iwamoto T, Ross R, Gershbein A, Chang S (1993) Retinal tolerance to intravitreal perfluoroethylcyclohexane liquid in the rabbit. Retina 13:56-62
33. Stolba U, Krepler K, Pflug R, Velikay M, Wedrich A, Binder S (1997) Experimental vitreous and aqueous replacement with perfluorophenanthrene. Clinical, histologic, and electrophysiologic results. Retina 17:146-153
34. Stolba U, Krepler K, Velikay-Parel M, Binder S (2004) The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution. Graefes Arch Clin Exp Ophthalmol 242:931-936
35. Theelen T, Tilanus M, Klevering BJ (2004) Intraocular inflammation following endotamponade with high-density silicone oil. Graefes Arch Clin Exp Ophthalmol 242:617-620
36. Tognetto D, Minutola D, Sanguinetti G, Ravalico G (2005) Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: A pilot study. Ophthalmology 112:1574-1578, Sep
37. Velikay M, Wedrich A, Stolba U, Datlinger P, Li Y, Binder S (1993) Experimental long-term vitreous replacement with purified and nonpurified perfluorodecalin. Am J Ophthalmol 116:565-570
38. Vote B, Wheen L, Cluroe A, Teoh H, McGeorge A (2003) Further evidence for proinflammatory nature of perfluorohexyloctane in the eye. Clin Exp Ophthalmol 31:408-414
39. Wolf S, Schon V, Meier P, Wiedemann P (2003) Silicone oil-RMN3 mixture ("heavy silicone oil") as internal tamponade for complicated retinal detachment. Retina 23:335-342
40. Wong D, Van Meurs JC, et al (2005) A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol 89:662-665
41. Wong D, Williams R, Stappler T, Groenewald C (2005) What pressure is exerted on the retina by heavy tamponade agents? Graefes Arch Clin Exp Ophthalmol 243:474-477
42. Yamamoto S, Takeuchi S (2000) Silicone oil and fluorosilicone. Semin Ophthalmol 15:15-24
43. Zeana D, Becker J, Kuckelkorn R, Kirchhof B (1999) Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution. Int Ophthalmol 23:17-24